Fox Chase Cancer Center: all 215 studies
Page 3 of 3. Open to participants first (30), then studies with results posted, then the rest; newest registration first within each.
- Carboplatin and Gemcitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00021346Phase 1
- Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung CancerCompletedNCT00021333Phase 2
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal CancerCompletedNCT00021320Phase 2
- Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma MultiformeWithdrawnNCT00021307Phase 1/2
- Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal CancerCompletedNCT00006387Phase 1
- SU5416 in Treating Patients With Refractory or Relapsed Multiple MyelomaCompletedNCT00006013Phase 2
- R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005848Phase 2
- Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung CancerCompletedNCT00005037Phase 2
- Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or LymphomaCompletedNCT00005021Phase 1
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's LymphomaCompletedNCT00003957Phase 2
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00003944Phase 2
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.CompletedNCT00003943Phase 2
- Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck CancerCompletedNCT00003264Phase 2
- Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural MesotheliomaCompletedNCT00003263Phase 1
- Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid TumorsCompletedNCT00003109Phase 1